(+-)-1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate |
081D530 |
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride |
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate |
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate |
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride |
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride |
113-07-5 |
113D075 |
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride |
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate |
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+-)- |
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride |
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate |
2-Pyrrolidinone,3-diphenyl-, monohydrochloride |
3,3-Diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride |
AC-4694 |
AC1L21NE |
AHR 619 |
AHR-619 |
AK-55670 |
AKOS015906444 |
AOB5785 |
API0002485 |
AS-13336 |
Bio-0166 |
C24H30N2O2 |
C24H30N2O2.HCl |
CAS-113-07-5 |
CCG-101076 |
CCG-221205 |
CHEBI:59837 |
CHEMBL1200876 |
CPD000469229 |
CTK8F9367 |
Doxapram HCL |
Doxapram hydrochloride [USAN:JAN] |
Doxapram hydrochloride anhydrous |
DSSTox_CID_27815 |
DSSTox_GSID_47837 |
DSSTox_RID_82579 |
DTXSID9047837 |
EINECS 204-022-3 |
FC1271 |
H927 |
J-002892 |
K-0985 |
LS-138812 |
MBGXILHMHYLZJT-UHFFFAOYSA-N |
MCULE-1905124271 |
MFCD00072148 |
MLS001424142 |
MolPort-005-973-141 |
NC00326 |
NCGC00167459-01 |
NCGC00167459-02 |
NSC-170958 |
NSC170958 |
SAM001246792 |
SCHEMBL40645 |
SMR000469229 |
Stimulexin |
Tox21_112463 |
Tox21_112463_1 |